A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Ocrelizumab in Participants With Relapsing Multiple Sclerosis and Primary Progressive Multiple Sclerosis
- Status
- RECRUITING
- Phase
- PHASE4
Clinical Trials Related to Primary Progressive Multiple Sclerosis
Related studies linked through entity extraction aliases.
Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Cognitive Performance, Sleep Disturbances and Fatigue in Multiple Sclerosis
- Status
- RECRUITING
- Phase
- N/A
Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis: A Trans-regional Digital Health Effort Unlocking the Potential of Artificial Intelligence and Data Science in Health Care
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A Study of Allogeneic Hematopoietic Cell Transplantation for Primary Progressive Multiple Sclerosis
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Effect of Ocrelizumab on Choroid Plexus Changes in Patients With PPMS
- Status
- COMPLETED
- Phase
- N/A
Effect of Ocrelizumab on Cortical Lesion Accumulation in Patients With PPMS (ORATORIO-Cortical)
- Status
- COMPLETED
- Phase
- N/A
Metformin Add-on Clinical Study in Multiple Sclerosis to Evaluate Brain Remyelination And Neurodegeneration
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Metformin Treatment in Progressive Multiple Sclerosis
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
A Phase III, Non-Inferiority, Randomized, Open-Label, Parallel Group, Multicenter Study To Investigate The Pharmacokinetics, Pharmacodynamics, Safety And Radiological And Clinical Effects Of Subcutaneous Ocrelizumab Versus Intravenous Ocrelizumab In Patients With Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE3
The Influence of HIIT Versus MCT on Cardiorespiratory Fitness in PPMS
- Status
- UNKNOWN
- Phase
- NA
Phase 1b Multiple Ascending Dose Study of Foralumab in Primary and Secondary Progressive MS
- Status
- WITHDRAWN
- Phase
- PHASE1
Gray Matter Demyelination in Primary Progressive MS at 7T
- Status
- RECRUITING
- Phase
- N/A
Intrathecal Administration of DUOC-01 in Adults With Primary Progressive Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE1
Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS)
- Status
- COMPLETED
- Phase
- PHASE3
SIZOMUS Safety of Ixazomib Targeting Plasma Cells in Multiple Sclerosis
- Status
- RECRUITING
- Phase
- PHASE1
Effect of Ocrelizumab on Brain Innate Immune Microglial Cells Activation in MS Using PET-MRI With 18F-DPA714
- Status
- UNKNOWN
- Phase
- PHASE3
Upper Extremity Function in Multiple Sclerosis Patients With Advanced Disability Treated With Ocrevus
- Status
- COMPLETED
- Phase
- N/A
Comparing Tolerability and Absorption of Racemic and R-lipoic Acid in Progressive Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE1